Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

Here is the AI research roadmap for 2026: how agents that learn, self-correct, and simulate the real world will redefine ...

Broadcom enters 2026 at an inflection point, with strong tailwinds from its ASIC and Networking segments. Read why AVGO stock is a Buy.

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Recursion Pharmaceuticals (NASDAQ: RXRX) experienced an 11% increase in stock price on Wednesday after JP Morgan raised its rating, noting the promising potential of its MEK inhibitor program. However ...

Notre Dame men's basketball coach Micah Shrewsberry charged at a referee during the team's Jan. 2 game after a controversial ...

Police returned fire, striking the suspect multiple times and killing him. Three police officers in Rochester, New York, were shot Friday night "without warning at close range" while responding to a ...

SANTA MARIA, Calif. (KEYT) – A 48-year-old Santa Maria man was arrested for assault with a firearm and multiple other gun-related charges Monday. On Sunday, Dec. 28, around 7:19 p.m., officers were ...

JPMorgan upgraded Recursion Pharmaceuticals (RXRX) to Overweight from Neutral with a price target of $11, up from $10. The firm says the company’s REC-4881 has shown “strong and durable” efficacy in ...

Santa Claus may be the busiest man on Christmas; however, he's still taking time out of his schedule to talk to all children, even the naughty ones. In addition to mall visits and responding to ...